Treatment with monoclonal antibodies against Clostridium difficile toxins.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

New therapies are needed to manage the increasing incidence, severity, and high rate of recurrence of Clostridium difficile infection.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

Read this article at

Abstract

Related collections

Special Issue: Management of Viral Hepatitis in the Post-Omics Era

Author and article information

Journal

Comments

Comment on this article